As of Thursday close, Johnson & Johnson’s (NYSE:JNJ) stock was down -$2.25, moving down -1.44 percent to $154.41. The average number of shares traded per day over the past five days has been 5,979,420 shares. 1 time new highs have been achieved over the past 5 days, with a -$4.07 fall in that time frame. In the last twenty days, the average volume was 5,718,890, while in the previous 50 days, it was 7,082,258.
Since last month, JNJ stock retreated -5.05%. Shares of the company fell to $153.72 on 05/25/23, the lowest level in the past month. A 52-week high of $183.35 was reached on 01/06/23 after having rallying from a 52-week low of $150.11. Since the beginning of this year, JNJ’s stock price has dropped by -12.59% or -$22.24, and marked a new high 3 times. However, the stock has declined by -15.78% since its 52-week high.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
JNJ stock investors should be aware that Johnson & Johnson (JNJ) stock had its last reported insider trading activity 81 days ago on Mar 06. Swanson James D., the of the company, disposed of 1,062 shares for $154.66 on Mar 06. It resulted in a $164,199 divestment by the insider. Wolk Joseph J sold 14,781 shares at an average price of $179.60 on Dec 13. The insider now owns 35,812 shares following the transaction. On Nov 30, EVP, WW Chair, MedTech McEvoy Ashley sold 73,323 shares at $175.47 apiece. The transaction was valued at $12,865,801.
Right now, Johnson & Johnson (JNJ) has a P/E ratio of about 32.30. The stock’s beta is 0.54. Besides these, the trailing price-to-sales (P/S) ratio of 4.16, the price-to-book (PB) ratio of 5.68, and the price-to-cash flow ratio of 91.58 may also be considered.
The latest dividend of $1.19 per share was paid out, which is 5.31% more than last year’s $1.13. On Tuesday April 18 2023, a $0.06 dividend increase was announced.
In the three months ended March 30, Johnson & Johnson’s quick ratio stood at 0.90, while its current ratio was 1.10, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.49, and the total debt-to-equity ratio was 0.75. On the profitability front, the trailing twelve-month gross margin is 67.00% percent. In the year ended March 30, EBITDA margin amounted to 33.42%, whereas operating margins totaled 15.70%. Based on annual data, JNJ earned $63.85 billion in gross profit and brought in $94.94 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 15.40%. Return on equity (ROE) for the past 12 months was 17.00%.
In Johnson & Johnson’s quarter-end financial report for March 30, it reported total debt of $34.93 billion against cash and short-term investments of $5.44 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. JNJ’s revenue rose 5.33% to $23.71 billion during the quarter, while net income inched up to $24.75 billion. While analysts expected Johnson & Johnson to report $2.5 quarterly earnings, the actual figure was $2.68 per share, beating the consensus estimate by 7.20%. During the quarter, the company generated $1.59 billion in EBITDA. The liabilities of Johnson & Johnson were 125.1 billion at the end of its most recent quarter ended March 30, and its total debt was $52.91 billion. The value of shareholders’ equity is $2.6 billion.
This quick technical analysis looks at Johnson & Johnson’s (JNJ) price momentum. With a historical volatility rate of 7.17%, the RSI 9-day stood at 17.94% on 25 May.
With respect to its five-day moving average, the current Johnson & Johnson price is down by -2.57% percent or -$4.07. At present, JNJ shares trade -5.27% below its 20-day simple moving average and -12.59% percent below its 100-day simple moving average. However, the stock is currently trading approximately +0.04% above its SMA50 and -9.27% below its SMA200.
Stochastic coefficient K was 8.19% and Stochastic coefficient D was 7.27%, while ATR was 2.01. Given the Stochastic reading of 7.80% for the 14-day period, the RSI (14) reading has been calculated as 28.57%. As of today, the MACD Oscillator reading stands at -1.82, while the 14-day reading stands at -3.10.
Johnson & Johnson (JNJ) has been rated Overweight by analysts. According to 0 brokerage firms, JNJ is a sell, and 14 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 3 analysts rate Johnson & Johnson stock as buy, with 5 recommending it as overweight.
With a median target price of $177.00, the current consensus forecast for the stock is $161.00 – $215.00. Based on these forecasts, analysts predict Johnson & Johnson (JNJ) will achieve an average price target of $179.69.